By blocking NF-κB/HIF-1α-mediated EMT and ECM remodeling, MTD effectively suppresses VM formation in ESCC under hypoxic tumor microenvironment conditions (Wang et al., 2025b). The gene discussed is HIF1A; the disease is neoplasm.